• Three cancer treatments approved for use on NHS Scotland pharmatimes
    July 11, 2018
    Three treatments have been approved for NHS funding in Scotland, bringing new options for gastroenteropancreatic tumours, lung and kidney cancers, but patients with multiple sclerosis will be unable to access Roche’s Ocrevus following a rejection by the S
PharmaSources Customer Service